Prophylactic antibiotic therapy in chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease

Volumn 4, Issue 3, 2010, Pages 135-142

  Maraffi, Tommaso ^a   Piffer, Federico ^a   Cosentini, Roberto ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

antibiotic prophylaxis; chronic bronchitis; chronic obstructive bronchopulmonary disease

Indexed keywords

CLARITHROMYCIN; CORTICOSTEROID; ERYTHROMYCIN; MACROLIDE; MOXIFLOXACIN; OLEANDOMYCIN PLUS TETRACYCLINE; OXYTETRACYCLINE; PENICILLIN V; PHENETICILLIN; PLACEBO; RIBOFLAVIN; SULFADIMIDINE; SULFAPHENAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOMODULATION; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY EPITHELIUM; REVIEW; RISK FACTOR; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CLINICAL TRIALS AS TOPIC; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77953348501     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465810368552     Document Type: Review

References (37)

1. Banerjee, D., Khair, O.A. and Honeybourne, D. ( 2004) Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 23: 685-691.
2. Banerjee, D., Khair, O.A. and Honeybourne, D. ( 2005) The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. Respir Med 99: 208-215.
3. Black, P., Staykova, T., Chacko, E., Ram, F.S. and Poole, P. ( 2003) Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst Rev 1: CD004105.
4. Crosbie, P.A. and Woodhead, M.A. (2009) Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J 33: 171-181.
5. Equi, A., Balfour-Lynn, I.M., Bush, A. and Rosenthal, M. ( 2002) Long term azithromycin in children with cystic fibrosis: A randomized, placebo-controlled crossover trial. Lancet 360: 978-984.
6. Evans, D.J., Bara, A.I. and Greenstone, M. ( 2007) Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database Syst Rev: CD001392.
7. Gold (2008) Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. Global Initiative for Chronic Obstructive Lung Disease.
8. Hill, A.T., Campbell, E.J., Hill, S.L., Bayley, D.L. and Stockley, R.A. ( 2000) Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109: 288-295.
9. Hurst, J.R. and Wedzicha, J.A. ( 2007) The biology of a chronic obstructive pulmonary disease exacerbation. Clin Chest Med 28: 525-536.
10. Johnston, S.L., Blasi, F., Black, P.N., Martin, R.J., Farrell, D.J. and Nieman, R.B.; Telicast Investigators ( 2006) The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354: 1589-1600.
11. Kudoh, S., Azuma, A., Yamamoto, M., Izumi, T. and Ando, M. ( 1998) Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157: 1829-1832.
12. McComb, J.M., Campbell, N.P. and Cleland, J. ( 1984) Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol 54: 922-923.
13. Malhotra-Kumar, S., Lammens, C., Coenen, S., Van Herck, K. and Goossens, H. ( 2007) Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: A randomized, double-blind, placebo-controlled study. Lancet 369: 482-490.
14. Mannino, D.M. and Buist, A.S. ( 2007) Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 370: 765-773.
15. Miravitlles, M., Marín, A., Monsó, E., Vilà, S., de la Roza, C., Hervás, R. et al. (2009) Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD. Eur Respir J 34: 1066-1071.
16. Monsó, E., Ruiz, J., Rosell, A., Manterola, J., Fiz, J., Morera, J. et al. (1995) Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 152: 1316-1320.
17. Monsó, E., Rosell, A., Bonet, G., Manterola, J., Cardona, P.J., Ruiz, J. et al. (1999) Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 13: 338-342.
18. Patel, I.S., Seemungal, T.A.R., Wilks, M., Owen, S.J., Donaldson, G.C. and Wedzicha, J.A. ( 2002) Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 57: 759-764.
19. Pépin, J., Sahib, N., Coulombe, M.A., Alary, M.E., Corriveau, M.P., Authier, S. et al. (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec. Clinical Infect Dis 41: 1254-1260.
20. Roede, B.M., Bresser, P., Prins, J.M., Schellevis, F., Verheij, T.J. and Bindels, P.J. ( 2008) Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: An historical population based cohort study. Thorax 63: 968-973.
21. Roede, B.M., Bresser, P., Prins, J.M., Schellevis, F., Verheij, T.J. and Bindels, P.J. (2009) Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD. Eur Respir J 33: 282-288.
22. Ryan, R.J., Lindsell, C. and Sheen, P. ( 2008) Fluoroquinolone resistance during 2000-2005: an observational study. BMC Infect Dis 8: 71.
23. Seemungal, T.A., Wilkinson, T.M., Hurst, J.R., Perera, W.R., Sapsford, R.J. and Wedzicha, J.A. ( 2008) Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 178: 1139-1147.
24. Sethi, S. and Alder, J. ( 2009) Intermittent moxifloxacin effective in reducing exacerbations, bacterial burden in patients with COPD - the PULSE study. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, 16-19 May 2009. Abstract number: P1789.
25. Sethi, S., Jones, P.W., Schmitt Theron, M., Miravitlles, M., Rubinstein, E., Wedzicha, J.A. et al.; PULSE Study Group (2010 ) Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial. Respir Res 11: 10 doi:10.1186/ 1465-9921-11-10.
26. Sethi, S., Maloney, J., Grove, L., Wrona, C. and Berenson, C.S. ( 2006) Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 991-998.
27. Shinkai, M., Henke, M.O. and Rubin, B.K. ( 2008) Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action. Pharmacol Ther 117: 393-405.
28. Southern, K.W., Barker, P.M. and Solis-Moya, A. ( 2004) Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev: CD002203. DOI: 10.1002/14651858.CD002203.pub2.
29. Suzuki, T., Yanai, M., Yamaya, M., Satoh-Nakagawa, T., Sekizawa, K., Ishida, S. et al. (2001) Erythromycin and common cold in COPD. Chest 120: 730-733.
30. Tsai, W.C., Rodriguez, M.L., Young, K.S., Deng, J.C., Thannickal, V.J., Tateda, K. et al. (2004) Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 170: 1331-1339.
31. Tsang, K.W., Ho, P.I., Chan, K.N., Ip, M.S., Lam, W.K., Ho, C.S. et al. (1999) A pilot study of low dose erythromycin in bronchiectasis. Eur Respir J 13: 361-364.
32. Verleden, G.M., Vanaudenaerde, B.M., Dupont, L.J. and Van Raemdonck, D.E. ( 2006) Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174: 566-570.
33. Weinreich, U.M. and Korsgaard, J. ( 2008) Bacterial colonization of lower airways in health and chronic lung disease. Clin Respir J 2: 116-122.
34. Wilkinson, T.M., Patel, I.S., Wilks, M., Donaldson, G.C. and Wedzicha, J.A. ( 2003) Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1090-1095.
35. Wolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. ( 2002) Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomized trial. Thorax 57: 212-216.
36. Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Ieven, M., Ortqvist, A. et al. (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26: 1138-1180.
37. Zalacain, R., Sobradillo, V., Militia, J., Amilibia, J., Barron, J., Achótegui, V. et al. (1999) Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 13: 343-348.